Paratek Pharmaceuticals, Inc.
Symbole: PRTK
NASDAQ
2.23
USDPrix du marché aujourd'hui
-3.0521
Ratio P/E
0.1791
Ratio PEG
127.83M
Cap MRK
- 0.00%
Rendement DIV
Paratek Pharmaceuticals, Inc. (PRTK) États financiers
Bilan
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 178.97 | 34.2 | 95.5 | 125.2 | |||||||||||||||||||||
balance-sheet.row.short-term-investments | 29.92 | 0 | 15.1 | 20 | |||||||||||||||||||||
balance-sheet.row.net-receivables | 190.45 | 78 | 33.1 | 15.7 | |||||||||||||||||||||
balance-sheet.row.inventory | 62.72 | 16.6 | 11 | 14.6 | |||||||||||||||||||||
balance-sheet.row.other-current-assets | 41.91 | 7.9 | 12.4 | 7.8 | |||||||||||||||||||||
balance-sheet.row.total-current-assets | 474.42 | 136.8 | 152.1 | 164.1 | |||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 8.63 | 2.4 | 2.6 | 3 | |||||||||||||||||||||
balance-sheet.row.goodwill | 3.32 | 0.8 | 0.8 | 0.8 | |||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 3.32 | 0.8 | 0.8 | 0.8 | |||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 140.11 | 32.5 | 28.4 | 8.9 | |||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 152.06 | 35.7 | 31.8 | 12.7 | |||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-assets | 626.48 | 172.5 | 183.9 | 176.9 | |||||||||||||||||||||
balance-sheet.row.account-payables | 21.68 | 5.3 | 5.4 | 1.8 | |||||||||||||||||||||
balance-sheet.row.short-term-debt | 164.04 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 872.3 | 258.4 | 255.7 | 252 | |||||||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||||
balance-sheet.row.other-current-liab | 91.2 | 32.1 | 25.9 | 22.1 | |||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 1042.35 | 306.2 | 280.4 | 255.2 | |||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 4.89 | 1.5 | 1.3 | 1.5 | |||||||||||||||||||||
balance-sheet.row.total-liab | 1354.08 | 343.6 | 311.7 | 279.1 | |||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.common-stock | 0.23 | 0.1 | 0.1 | 705.5 | |||||||||||||||||||||
balance-sheet.row.retained-earnings | -3769.48 | -930.4 | -866.9 | -807.8 | |||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -0.12 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 3041.77 | 759.4 | 739.1 | 0 | |||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | -727.6 | -171 | -127.8 | -102.3 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 626.48 | 172.5 | 183.9 | 176.8 | |||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-equity | -727.6 | -171 | -127.8 | -102.3 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 626.48 | - | - | - | |||||||||||||||||||||
Total Investments | 29.92 | 0 | 15.1 | 20 | |||||||||||||||||||||
balance-sheet.row.total-debt | 1036.34 | 258.4 | 255.7 | 252 | |||||||||||||||||||||
balance-sheet.row.net-debt | 887.3 | 224.2 | 175.4 | 146.9 |
Tableau des flux de trésorerie
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -62.73 | -63.6 | -59.1 | -96.5 | |||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0.31 | 0.5 | 0.4 | 0.6 | |||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 1.1 | |||||||||||||||||||
cash-flows.row.stock-based-compensation | 10.34 | 12.3 | 14.3 | 10.2 | |||||||||||||||||||
cash-flows.row.change-in-working-capital | 23.96 | -20.8 | -8.2 | -20.3 | |||||||||||||||||||
cash-flows.row.account-receivables | -5.71 | -40.4 | -21.8 | -7.5 | |||||||||||||||||||
cash-flows.row.inventory | -2.05 | -9.1 | -15.5 | -11.8 | |||||||||||||||||||
cash-flows.row.account-payables | 8.96 | 7.7 | 6.8 | 1.6 | |||||||||||||||||||
cash-flows.row.other-working-capital | 22.76 | 21 | 22.3 | -2.6 | |||||||||||||||||||
cash-flows.row.other-non-cash-items | 4.91 | 5.4 | 4.3 | 1.5 | |||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -23.22 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -0.07 | 0 | -0.4 | -0.4 | |||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.purchases-of-investments | -15.16 | -15.2 | -15.1 | -29.6 | |||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 30 | 30 | 20 | 122.5 | |||||||||||||||||||
cash-flows.row.other-investing-activites | 15.2 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 29.97 | 14.8 | 4.5 | 92.5 | |||||||||||||||||||
cash-flows.row.debt-repayment | -3.73 | -2.9 | -0.3 | -70 | |||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 7.3 | 18.4 | 21.9 | |||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.other-financing-activites | -0.12 | 0.7 | 0.3 | 59.4 | |||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -3.57 | 5.1 | 18.3 | 11.3 | |||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.net-change-in-cash | 3.18 | -46.2 | -25.4 | 0.4 | |||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 149.55 | 34.4 | 80.6 | 106 | |||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 146.37 | 80.6 | 106 | 105.6 | |||||||||||||||||||
cash-flows.row.operating-cash-flow | -23.22 | -66.1 | -48.3 | -103.4 | |||||||||||||||||||
cash-flows.row.capital-expenditure | -0.07 | 0 | -0.4 | -0.4 | |||||||||||||||||||
cash-flows.row.free-cash-flow | -23.29 | -66.2 | -48.6 | -103.8 |
Row du compte de résultat
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 167.74 | 150.8 | 121 | 43.5 | ||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 25.3 | 23.1 | 21.5 | 8.7 | ||||||||||||||||||||||
income-statement-row.row.gross-profit | 142.45 | 127.7 | 99.4 | 34.9 | ||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
income-statement-row.row.research-development | 38.83 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.other-expenses | -7.38 | -9.5 | -9.2 | -3.4 | ||||||||||||||||||||||
income-statement-row.row.operating-expenses | 186.99 | 173.9 | 140.5 | 110.4 | ||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 212.29 | 197 | 162.1 | 119 | ||||||||||||||||||||||
income-statement-row.row.interest-income | 0.99 | 0.8 | 0.1 | 1.5 | ||||||||||||||||||||||
income-statement-row.row.interest-expense | 18.86 | 18.1 | 17.4 | 20.2 | ||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -12.98 | -17.3 | -17.4 | -21 | ||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -7.38 | -9.5 | -9.2 | -3.4 | ||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | -12.98 | -17.3 | -17.4 | -21 | ||||||||||||||||||||||
income-statement-row.row.interest-expense | 18.86 | 18.1 | 17.4 | 20.2 | ||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0.95 | 1.3 | 0.4 | 1.6 | ||||||||||||||||||||||
income-statement-row.row.ebitda-caps | -43.4 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.operating-income | -44.54 | -46.2 | -41.1 | -75.5 | ||||||||||||||||||||||
income-statement-row.row.income-before-tax | -62.56 | -63.5 | -58.5 | -96.5 | ||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 4.56 | 0.1 | 0.6 | 19.7 | ||||||||||||||||||||||
income-statement-row.row.net-income | -67.12 | -63.6 | -59.1 | -116.3 |
Questions fréquemment posées
Quel est le total de Paratek Pharmaceuticals, Inc. (PRTK) de l'actif total?
Paratek Pharmaceuticals, Inc. (PRTK) Le total des actifs est 172538000.000.
Quel est le revenu annuel de l'entreprise?
Le revenu annuel est 67270000.000.
Quelle est la marge bénéficiaire de l'entreprise?
La marge bénéficiaire de l'entreprise est 0.850.
Quel est le flux de trésorerie disponible de l'entreprise?
Le flux de trésorerie disponible est -0.190.
Quelle est la marge bénéficiaire nette de l'entreprise?
La marge bénéficiaire nette est -0.299.
Quel est le revenu total de l'entreprise?
Le revenu total est -0.201.
Qu'est-ce que Paratek Pharmaceuticals, Inc. (PRTK) bénéfice net (revenu net)?
Le bénéfice net (revenu net) est -63566000.000.
Quel est l'endettement total de l'entreprise?
La dette totale est 258414000.000.
Quel est le montant des dépenses d'exploitation?
Les dépenses d'exploitation sont 173941000.000.
Quel est le montant de la trésorerie de l'entreprise?
Les liquidités de l'entreprise sont 42685000.000.